Fiji Cannot Keep Calling This Progress While Patients Still Suffer

-



Fiji has taken a limited step forward by creating a legal pathway for industrial hemp cultivation. Yet despite this change, patients suffering from serious medical conditions remain unable to legally access cannabis-based medicines under a regulated medical framework.

This contradiction is becoming increasingly difficult to justify.

If cannabis can be cultivated, processed, researched, and commercialized for industrial purposes, why does Fiji still deny patients access to medically supervised cannabis treatments that are legally available in many countries around the world?

This is not a debate about recreational cannabis.

It is a debate about healthcare.

It is a debate about whether patients should have access to every evidence-based treatment option that may improve their quality of life.

The scientific evidence supporting medical cannabis is strongest in several specific areas. Cannabis-based medicines have demonstrated effectiveness in reducing chemotherapy-induced nausea and vomiting, treating certain forms of treatment-resistant epilepsy, and helping manage spasticity associated with multiple sclerosis.[1][2] Evidence also suggests some patients with chronic pain may experience meaningful relief, particularly when conventional treatments have proven ineffective.[3]

Medical cannabis is not a miracle cure.

It does not cure cancer.

It does not cure epilepsy.

It does not cure multiple sclerosis.

However, for some patients, it can reduce suffering, improve quality of life, and provide relief where other treatments have failed.

That is why countries including Canada, Germany, Australia, Israel, New Zealand, and many others have established regulated medical cannabis programs.[4] These systems allow doctors to prescribe cannabis-based medicines under strict medical oversight, while maintaining safeguards such as product testing, quality control, patient eligibility requirements, and monitoring systems.

The existence of these programs demonstrates an important reality: medical cannabis regulation and public safety are not mutually exclusive.

Fiji does not have to choose between prohibition and chaos.

There is a middle path.

A carefully regulated medical cannabis framework will allow eligible patients access to treatment while maintaining strong controls to prevent misuse.

The strongest argument against medical cannabis is that more research remains necessary and that cannabis carries potential risks. This is true. Like all medicines, cannabis-based treatments can cause side effects and may not be appropriate for every patient.[5]

But acknowledging risks should not end the conversation.

The purpose of modern healthcare is not to eliminate all risk; it is to balance risks against potential benefits and allow informed medical decisions based on evidence.

For patients facing cancer treatment, severe epilepsy, chronic pain, and other debilitating conditions, that balance may justify access under professional medical supervision.

Fiji's policymakers should be willing to examine the evidence objectively and engage in an honest national discussion about medical cannabis reform.

Patients deserve compassion.

Doctors deserve evidence-based treatment options.

Families deserve hope.

And Fiji deserves a policy guided by science, public health, and human dignity rather than fear, stigma, and outdated assumptions.

The question is no longer whether medical cannabis exists as a legitimate medical treatment.

The question is whether Fiji is prepared to have a serious conversation about allowing patients legal access to it.

References

[1] National Academies of Sciences, Engineering, and Medicine. The Health Effects of Cannabis and Cannabinoids: The Current State of Evidence and Recommendations for Research. Washington, DC: National Academies Press, 2017.

[2] World Health Organization (WHO). Cannabis and Cannabis-Related Substances: Critical Review Report.

[3] Whiting PF, Wolff RF, Deshpande S, et al. "Cannabinoids for Medical Use: A Systematic Review and Meta-analysis." JAMA. 2015;313(24):2456–2473.

[4] Government regulatory frameworks for medical cannabis in Canada, Germany, Australia, Israel, and New Zealand.

[5] National Center for Complementary and Integrative Health (NCCIH). Cannabis (Marijuana) and Cannabinoids: What You Need To Know.

Cannabis Fiji

"Patients Before Politics. Science Before Stigma."

Yandra Mai Viti

Sign the petition for Cannabis Reform in Fiji: https://www.change.org/p/decriminalize-cannabis-in-fiji-for-our-health-wealth-and-justice?fbclid=IwdGRjcASd8_pjbGNrBJ3z9mV4dG4DYWVtAjExAHNydGMGYXBwX2lkDDM1MDY4NTUzMTcyOAABHnVgsDVvp6QXvfaCmTr89UQ0IVQlJp6WN75K8ibKY-LeMk7Yc-IRO9OecrEa_aem_YWdncwCgJ6hZLGC_F5i_v-2iJozx&brid=YWdncwFG04EuSVmGPz-bQ_JYajSC

.

.

.

#CannabisFiji #LegalizingFijiCannabis #ForOurWealthAndWHealthFiji #FijiCannabisCommunity #FijiWeed #FijiMarijuana #FijiTHC #FijiCBD #FijiCannabisCulture #WeedPorn #FijiMedicalCannabis #FijiStone #FijiHemp #MaryJaneFiji #KushFiji #CBD #MedicalMarijuanaFiji #GanjaFiji #GrowYourOwn #CannabisSocietyFiji #Cannabis #LegalizeIt #HighSociety #SmokeWeedEveryday





Comments

Post a Comment

Popular posts from this blog

Fiji’s Hemp Promise: More Than Three Years Lost

-
In July 2022, Fiji’s Parliament amended the Illicit Drugs Control Act to legalize industrial hemp, removing low-THC hemp from the list of prohibited substances. At the time, it was framed as a step toward economic diversification, sustainable agriculture, and new opportunities for local farmers. More than three years later, that promise remains largely unfulfilled. Hemp is legal in law — but not functional in practice. Clear regulations, licensing systems, and customs alignment have still not been fully implemented. As a result, Fiji has watched a global industry grow while remaining effectively locked out of it. This is not a debate about ideology or morality. It is about time lost, income lost, and opportunities denied. The global reality: hemp moved forward without Fiji Since 2022, the global industrial hemp industry has continued to expand. Independent market analysts estimate the global hemp market to be worth around USD 9–11 billion by 2024, with strong growth projected into the ...
Read more

World Moves Forward on Cannabis Science — Fiji Still Enforcing Outdated Laws That Punish Locals and Undermines Its Own Economic Credibility

-
The global trajectory on cannabis policy is shifting — cautiously, unevenly, but unmistakably — toward alignment with scientific evidence rather than inherited prohibition. In the United States, the Trump administration has publicly indicated consideration of moving cannabis from Schedule I — the most restrictive federal classification — toward Schedule III. As of now, no final rescheduling order has been completed, and the process remains subject to administrative review and procedural delay. Still, the discussion itself marks a significant break from decades of rigid federal positioning. A move to Schedule III would formally recognize that cannabis has accepted medical use and a lower abuse profile than Schedule I substances, potentially easing research barriers and correcting tax distortions. It would not legalize cannabis federally, nor would it eliminate federal enforcement powers — but it would represent a scientific and regulatory recalibration long delayed. While major economie...
Read more

“All Communities Free to Do Business” — Except When the Business Is Cannabis

-
“All Communities Free to Do Business” — Except When the Business Is Cannabis On 13 December 2025, Prime Minister Sitiveni Rabuka stated at the opening of the George Shiu Raj Complex in Rakiraki that “all ethnic communities in Fiji are safe, protected and free to pursue their economic interests.” That statement was made in a celebratory context about private investment and inclusive growth. But when examined against the Government’s existing laws and policies on cannabis — especially its export-only orientation and absence of an operational domestic cannabis regime — the assurance does not align with the evidence. Claim vs. Legal Reality The Prime Minister’s assurance implies sector-neutral economic freedom. Yet, under Fiji’s current legal framework: Cannabis remains illegal for general cultivation, possession, supply, and use under the Illicit Drugs Control Act, except where narrowly exempted (i.e., industrial hemp under 1% THC). All other forms of cannabis remain classified as illicit...
Read more